MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 24 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,487,000 | +95.1% | 597,026 | +30.6% | 2.36% | +50.8% |
| Q2 2022 | $2,812,000 | +15.2% | 457,200 | +20.3% | 1.57% | +37.5% |
| Q1 2022 | $2,440,000 | -70.0% | 380,000 | -25.3% | 1.14% | -43.5% |
| Q4 2019 | $8,141,000 | +18.1% | 508,500 | +37.6% | 2.02% | -59.5% |
| Q3 2019 | $6,891,000 | -26.9% | 369,500 | +6.5% | 4.97% | +48.5% |
| Q2 2019 | $9,421,000 | – | 347,000 | – | 3.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,928,752 | $12,383,000 | 1.63% |
| ACUTA CAPITAL PARTNERS, LLC | 380,000 | $2,440,000 | 1.14% |
| Lion Point Capital, LP | 683,570 | $4,388,000 | 1.02% |
| Novo Holdings A/S | 2,530,003 | $16,243,000 | 0.86% |
| Boxer Capital, LLC | 2,238,861 | $14,373,000 | 0.74% |
| RTW INVESTMENTS, LP | 4,315,102 | $27,703,000 | 0.57% |
| RA Capital Management | 2,246,503 | $14,423,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,605,000 | 0.28% |
| Orbimed Advisors | 2,583,821 | $16,588,000 | 0.27% |
| PURA VIDA INVESTMENTS, LLC | 987,411 | $6,339,000 | 0.21% |